Lightcast is a biotechnology company that specializes in AI-driven drug discovery and development. The company has established an Innovation Center in the United States to support the global expansion of its Luminary Early Access Program, which aims to democratize access to AI-driven drug discovery for researchers worldwide.

Lightcast

Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational and basic research as well as streamline development workflows for drugs, therapeutics, and applied biologics.

BIO:LIGHTCAST

Lightcast

Financials Not Available